| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 375142VBIA |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Transforming growth factor beta-1 inhibitor | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Glomerulosclerosis, Focal Segmental | 2 | D005923 | ClinicalTrials |
| Brain Neoplasms | 2 | D001932 | ClinicalTrials |
| Mesothelioma | 2 | D008654 | ClinicalTrials |
| Osteogenesis Imperfecta | 1 | D010013 | ClinicalTrials |
| Carcinoma, Renal Cell | 1 | D002292 | ClinicalTrials |
| Idiopathic Pulmonary Fibrosis | 1 | D054990 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Scleroderma, Diffuse | 1 | D045743 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 948564-73-6 |
| ChEMBL | CHEMBL1743022 |
| FDA SRS | 375142VBIA |
| Guide to Pharmacology | 8264 |
CONTENTS